FR2832633B1 - Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete - Google Patents
Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabeteInfo
- Publication number
- FR2832633B1 FR2832633B1 FR0115398A FR0115398A FR2832633B1 FR 2832633 B1 FR2832633 B1 FR 2832633B1 FR 0115398 A FR0115398 A FR 0115398A FR 0115398 A FR0115398 A FR 0115398A FR 2832633 B1 FR2832633 B1 FR 2832633B1
- Authority
- FR
- France
- Prior art keywords
- alkyl
- aryl
- metformin
- oxo
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0115398A FR2832633B1 (fr) | 2001-11-28 | 2001-11-28 | Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete |
RU2004119817/15A RU2004119817A (ru) | 2001-11-28 | 2002-11-06 | Фармацевтическая композиция, содержащая метформин в сочетании с 4-оксомасляной кислотой, и их применение для лечения диабета |
KR10-2004-7006791A KR20040058266A (ko) | 2001-11-28 | 2002-11-06 | 메트포르민 및 4-옥소부탄산의 조합물을 포함하여이루어지는 약제학적 조성물 및 당뇨병을 치료하기 위한이의 용도 |
EP02787576A EP1448181B1 (fr) | 2001-11-28 | 2002-11-06 | Composition pharmaceutique contenant une combinaison de metformine et d'un acide 4-oxobutanoique et son utilisation pour traiter le diabete |
ES02787576T ES2266605T3 (es) | 2001-11-28 | 2002-11-06 | Composicion farmaceutica que comprende una combinacion de metformin y un acido 4-oxobutanoico y su uso para el tratamiento de la diabetes. |
JP2003546870A JP2005515984A (ja) | 2001-11-28 | 2002-11-06 | メトホルミンと4−オキソブタン酸の組合せを有する薬剤組成物、および糖尿病治療へのその適用 |
AT02787576T ATE327746T1 (de) | 2001-11-28 | 2002-11-06 | Pharmazeutische zubereitung enthaltend eine kombination aus metformin und a 4-oxobutanonsäure und ihre verwendung zur behandlung von diabetes |
MXPA04005033A MXPA04005033A (es) | 2001-11-28 | 2002-11-06 | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. |
CA002468280A CA2468280A1 (fr) | 2001-11-28 | 2002-11-06 | Composition pharmaceutique contenant une combinaison de metformine et d'un acide 4-oxobutanoique et son utilisation pour traiter le diabete |
US10/497,145 US20050020609A1 (en) | 2001-11-28 | 2002-11-06 | Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
PT02787576T PT1448181E (pt) | 2001-11-28 | 2002-11-06 | Composicao farmaceutica compreendendo uma combinacao de metformina de um acido 4-oxobutanoico e o seu uso no tratamento da diabetes |
AU2002351848A AU2002351848A1 (en) | 2001-11-28 | 2002-11-06 | Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
CNA028228375A CN1592615A (zh) | 2001-11-28 | 2002-11-06 | 含有二甲双胍和4-氧代丁酸的药物组合物及其在治疗糖尿病中的用途 |
DK02787576T DK1448181T3 (da) | 2001-11-28 | 2002-11-06 | Farmaceutisk præparat som omfatter en kombination af metformin og en 4-oxobutansyre og anvendelse deraf til behandling af diabetes |
BR0214487-5A BR0214487A (pt) | 2001-11-28 | 2002-11-06 | Composição farmacêutica que compreende uma combinação de metformina e um ácido 4-oxobutanóico, e o uso da mesma para o tratamento de diabetes |
PCT/EP2002/012355 WO2003045368A1 (fr) | 2001-11-28 | 2002-11-06 | Composition pharmaceutique contenant une combinaison de metformine et d'un acide 4-oxobutanoique et son utilisation pour traiter le diabete |
DE60211938T DE60211938T2 (de) | 2001-11-28 | 2002-11-06 | Pharmazeutische zusammensetzung enthaltend eine kombination aus metformin und einer 4-oxobutansäure und ihre verwendung zur behandlung von diabetes |
PL02369894A PL369894A1 (en) | 2001-11-28 | 2002-11-06 | Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
HU0402241A HUP0402241A2 (hu) | 2001-11-28 | 2002-11-06 | Metformin és 4-oxo-butánsav kombinációját tartalmazó gyógyászati készítmény, és a készítmény alkalmazása diabétesz kezelésére |
SI200230383T SI1448181T1 (sl) | 2001-11-28 | 2002-11-06 | Farmacevtski sestavek, ki obsega kombinacijo metformina in 4-oksobutanojske kisline, ter njegova uporaba za zdravljenje diabetesa |
TW091134094A TW200300341A (en) | 2001-11-28 | 2002-11-22 | Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
ZA200405021A ZA200405021B (en) | 2001-11-28 | 2004-06-24 | Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes. |
CY20061101178T CY1105165T1 (el) | 2001-11-28 | 2006-08-23 | Φαρμακευτικη συνθεση που πepιλαμβανει συνδυασμο μετφορμινης και 4-οξοβουτανικου οξεος και η χρηση αυτης για τη θepαπεια του διαβητη |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0115398A FR2832633B1 (fr) | 2001-11-28 | 2001-11-28 | Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2832633A1 FR2832633A1 (fr) | 2003-05-30 |
FR2832633B1 true FR2832633B1 (fr) | 2004-09-24 |
Family
ID=8869889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0115398A Expired - Fee Related FR2832633B1 (fr) | 2001-11-28 | 2001-11-28 | Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete |
Country Status (22)
Country | Link |
---|---|
US (1) | US20050020609A1 (fr) |
EP (1) | EP1448181B1 (fr) |
JP (1) | JP2005515984A (fr) |
KR (1) | KR20040058266A (fr) |
CN (1) | CN1592615A (fr) |
AT (1) | ATE327746T1 (fr) |
AU (1) | AU2002351848A1 (fr) |
BR (1) | BR0214487A (fr) |
CA (1) | CA2468280A1 (fr) |
CY (1) | CY1105165T1 (fr) |
DE (1) | DE60211938T2 (fr) |
DK (1) | DK1448181T3 (fr) |
ES (1) | ES2266605T3 (fr) |
FR (1) | FR2832633B1 (fr) |
HU (1) | HUP0402241A2 (fr) |
MX (1) | MXPA04005033A (fr) |
PL (1) | PL369894A1 (fr) |
PT (1) | PT1448181E (fr) |
RU (1) | RU2004119817A (fr) |
TW (1) | TW200300341A (fr) |
WO (1) | WO2003045368A1 (fr) |
ZA (1) | ZA200405021B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1752147A4 (fr) * | 2004-06-04 | 2007-10-31 | Kowa Co | Médicament pour la prévention ou le traitement du diabète |
EP1792580A1 (fr) | 2005-09-27 | 2007-06-06 | Ziterion GmbH | Implants dentaires en deux parties faites de céramique biocompatible |
EP1967157A1 (fr) | 2007-03-05 | 2008-09-10 | Ziterion GmbH | Implant dentaire hybride bipartite |
EP2106767A1 (fr) | 2008-03-31 | 2009-10-07 | Ziterion GmbH | Implant dentaire bipartite |
GB201004058D0 (en) * | 2010-03-11 | 2010-04-28 | Consiglio Nazionale Ricerche | Diagnostic assay for obesity and related disorders |
JP7527275B2 (ja) * | 2018-09-28 | 2024-08-02 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | メトホルミンの作用を増強する化合物 |
CN114349665B (zh) * | 2021-11-30 | 2023-06-09 | 潍坊博创国际生物医药研究院 | 二甲双胍焦谷氨酸晶体及其制备方法与应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863915A (en) * | 1996-05-15 | 1999-01-26 | Bayer Corporation | Substituted 4-arylbutyric acid derivatives as matrix metalloprotease |
FR2752422B1 (fr) * | 1996-08-16 | 1998-11-06 | Lipha | Composition pharmaceutique contenant des acides 4-oxo-butanoiques |
US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
GB9922710D0 (en) * | 1999-09-24 | 1999-11-24 | Bayer Ag | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis |
US6296874B1 (en) * | 2000-05-01 | 2001-10-02 | Aeropharm Technology Incorporated | Core formulation comprising troglitazone and abiguanide |
-
2001
- 2001-11-28 FR FR0115398A patent/FR2832633B1/fr not_active Expired - Fee Related
-
2002
- 2002-11-06 MX MXPA04005033A patent/MXPA04005033A/es not_active Application Discontinuation
- 2002-11-06 HU HU0402241A patent/HUP0402241A2/hu unknown
- 2002-11-06 PT PT02787576T patent/PT1448181E/pt unknown
- 2002-11-06 AT AT02787576T patent/ATE327746T1/de not_active IP Right Cessation
- 2002-11-06 RU RU2004119817/15A patent/RU2004119817A/ru not_active Application Discontinuation
- 2002-11-06 CA CA002468280A patent/CA2468280A1/fr not_active Abandoned
- 2002-11-06 PL PL02369894A patent/PL369894A1/xx not_active Application Discontinuation
- 2002-11-06 US US10/497,145 patent/US20050020609A1/en not_active Abandoned
- 2002-11-06 WO PCT/EP2002/012355 patent/WO2003045368A1/fr active IP Right Grant
- 2002-11-06 BR BR0214487-5A patent/BR0214487A/pt not_active IP Right Cessation
- 2002-11-06 DK DK02787576T patent/DK1448181T3/da active
- 2002-11-06 JP JP2003546870A patent/JP2005515984A/ja active Pending
- 2002-11-06 KR KR10-2004-7006791A patent/KR20040058266A/ko not_active Application Discontinuation
- 2002-11-06 CN CNA028228375A patent/CN1592615A/zh active Pending
- 2002-11-06 EP EP02787576A patent/EP1448181B1/fr not_active Expired - Lifetime
- 2002-11-06 DE DE60211938T patent/DE60211938T2/de not_active Expired - Fee Related
- 2002-11-06 ES ES02787576T patent/ES2266605T3/es not_active Expired - Lifetime
- 2002-11-06 AU AU2002351848A patent/AU2002351848A1/en not_active Abandoned
- 2002-11-22 TW TW091134094A patent/TW200300341A/zh unknown
-
2004
- 2004-06-24 ZA ZA200405021A patent/ZA200405021B/en unknown
-
2006
- 2006-08-23 CY CY20061101178T patent/CY1105165T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
TW200300341A (en) | 2003-06-01 |
HUP0402241A2 (hu) | 2005-02-28 |
BR0214487A (pt) | 2004-10-19 |
DK1448181T3 (da) | 2006-09-04 |
MXPA04005033A (es) | 2004-08-11 |
US20050020609A1 (en) | 2005-01-27 |
DE60211938T2 (de) | 2007-05-24 |
RU2004119817A (ru) | 2005-04-20 |
ZA200405021B (en) | 2005-05-30 |
DE60211938D1 (de) | 2006-07-06 |
ATE327746T1 (de) | 2006-06-15 |
AU2002351848A1 (en) | 2003-06-10 |
EP1448181A1 (fr) | 2004-08-25 |
WO2003045368A1 (fr) | 2003-06-05 |
EP1448181B1 (fr) | 2006-05-31 |
PT1448181E (pt) | 2006-10-31 |
KR20040058266A (ko) | 2004-07-03 |
ES2266605T3 (es) | 2007-03-01 |
CN1592615A (zh) | 2005-03-09 |
FR2832633A1 (fr) | 2003-05-30 |
CA2468280A1 (fr) | 2003-06-05 |
CY1105165T1 (el) | 2010-03-03 |
PL369894A1 (en) | 2005-05-02 |
JP2005515984A (ja) | 2005-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0412219A (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para regular a transdução de sinal método para tratamento ou prevenção de uma doença | |
JP2011516565A5 (fr) | ||
DK2017276T3 (da) | Phenylcarboxamid-forbindelser til behandling af smerte | |
DE60126947D1 (de) | Behandlung der glykogenspeicherkrankheit typ ii | |
NO20052130L (no) | Sterk inhibitor for HCV-serin-protease | |
ATE448199T1 (de) | Verbindungen mit taxol-verstärkender wirkung | |
ATE232862T1 (de) | Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen | |
EP1312601A4 (fr) | Derives d'acide carboxylique, procede de production de ceux-ci et medicaments contenant ceux-ci comme principe actif | |
WO2004029031A3 (fr) | Agents therapeutiques utiles dans le traitement de la douleur | |
FR2832633B1 (fr) | Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete | |
EP1314719A4 (fr) | Derives d'acide benzoique et medicaments possedant ces derniers comme principe actif | |
RU94044356A (ru) | Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с | |
DE60225143D1 (de) | Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes | |
ATE364586T1 (de) | Steigerung der wirksamkeit von wirkstoffen durch micellare zubereitung mit retinolderivaten | |
SE0002476D0 (sv) | New compounds | |
RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
WO2002064552A8 (fr) | DERIVE DE α-AMINO-N-HYDROXY-ACETAMIDE | |
DE60018186D1 (de) | Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie | |
DE502004005055D1 (de) | Oxaliplatinlösungskonzentrate | |
ATE447953T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis | |
BR0112216A (pt) | Composto, formulação farmaceutica, métodos para o tratamento de diabetes mellitus tipo ii em um paciente em necessidade do mesmo, para inibir a atividade de irosina fosfatase, para inibir a atividade de ptp-b1 em um mamìfero, de atividade cdc25a em um mamìfero, e uso do composto | |
CA2411418A1 (fr) | Derives hydroxyformamidine et medicaments les contenant | |
ATE352317T1 (de) | Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen | |
GB9216859D0 (en) | Medicaments | |
BRPI0406840A (pt) | Derivados de acil-fenil-uréia substituìdos por carbonilamino, processos para a sua preparação e sua aplicação |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20060731 |